ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Metabolic complications"

  • 2022 American Transplant Congress

    Bisphosphonates for Fracture Prevention in Kidney Transplant Recipients

    J. Kahwaji1, S. Yang2, J. Sim3

    1Nephrology/Transplant, Kaiser Los Angeles Medical Center, Los Angeles, CA, 2Research and Evaluation, Kaiser-Permanente, Pasadena, CA, 3Nephrology, Kaiser Los Angeles Medical Center, Los Angeles, CA

    *Purpose: Kidney transplant recipients are at increased risk of fracture, however bisphosphonate use has not be shown to lower fracture risk in this population. We…
  • 2022 American Transplant Congress

    The Impact of New-Onset Diabetes After Transplantation on Survival and Major Cardiovascular Events in Korean Kidney Transplantation Recipients

    E. Kang1, J. Lee2, D. Kang3, Y. Jang4, S. Park5, Y. Kim4, D. Kim4, K. Joo4, Y. Kim4, M. Park6, Y. Lim7, H. Lee4

    1Ewha Womans University Seoul Hospital, Seoul, Korea, Republic of, 2Dongguk University Ilsan Hospital, Goyang, Korea, Republic of, 3Chung-Ang University, Seoul, Korea, Republic of, 4Seoul National University Hospital, Seoul, Korea, Republic of, 5Seoul National University College of Medicine, Seoul, Korea, Republic of, 6Informations and Statistics, Chungnam National University, Daejeon, Korea, Republic of, 7Applied Statistics, Chung-Ang University, Seoul, Korea, Republic of

    *Purpose: New-onset diabetes after transplantation (NODAT) is a frequent complication in kidney transplant (KT) recipients with unfavorable outcomes, although a nationwide study on epidemiology and…
  • 2022 American Transplant Congress

    Single Center Retrospective Study Examining the Safety of the New Potassium- Binders for Post-Operative Hyperkalemia in Kidney Transplant Recipients

    S. Kapoor1, A. Campbell2, Y. Azzi1, L. E. Liriano-Ward3, T. Shertel4, W. Xiao5, D. U. Nnani6, S. Farghaly1, S. Yun7, E. Akalin1, M. Ajaimy1

    1Einstein-Montefiore Transplant Center, Bronx, NY, 2Montefiore Medical Center, Bronx, NY, 3Transplant, Montefiore Medical Center, Bronx, NY, 4-, -, AL, 5Albert Einstein College of Medicine, Folsom, CA, 6Pharmacy, Montefiore Medical Center, Bronx, NY, 7Montefiore Medical Center, New York, NY

    *Purpose: We aimed to evaluate the safety and efficacy of two potassium-binders (Patiromer and Sodium Zirconium Cyclosilicate (SZC) in early post-transplant hyperkalemia treatment of kidney…
  • 2022 American Transplant Congress

    The Impact of Donor’s Metabolic Syndrome Factor on Living Kidney Transplantation

    Y. Miyauchi, T. Noda, N. Miura, T. Kikugawa, T. Saika

    Ehime University, Toon, Japan

    *Purpose: Because donors for kidney transplantation are also aging in Japan, it is not uncommon that donors have metabolic syndrome (Met-S). It is necessary to…
  • 2022 American Transplant Congress

    Defining the Characteristics and Graft Outcomes of Kidney Transplant Recipients with Pre-Transplant Elevated Plasma Oxalate Levels

    D. Khan, N. Zhang, M. Keddis

    Mayo Clinic, Scottsdale, AZ

    *Purpose: The objective of this study is to compare graft outcomes for patients with pre-transplant elevated plasma oxalate (Pox) compared to a matched cohort.*Methods: Kidney…
  • 2022 American Transplant Congress

    A Large-Scale National Cohort Study Assessing the Impact of Diabetes and Obesity on Kidney Transplant Outcomes

    V. Rohan1, M. Casey1, S. Zemin2, P. Baliga2, D. Taber2

    1Surgery, Medical University of South Carolina, Charleston, SC, 2Medical University of South Carolina, Charleston, SC

    *Purpose: Type 2 Diabetes Mellitus (T2DM) is the most common cause of renal failure in patients undergoing kidney transplantation (KT) and highly correlated with obesity.…
  • 2022 American Transplant Congress

    Glucose Variability in Kidney Transplantation: Pre-Transplant and Post-Transplant Continuous Glucose Monitoring

    E. Jo1, A. Han2, S. Min2, J. Ha3, H. Lee4, A. Cho5

    1Surgery, Seoul National University Hospital, Seoul, Korea, Republic of, 2Seoul National University College of Medicine, Seoul, Korea, Republic of, 3Seoul Nat'l Univ. College of Medicine, Seoul, Korea, Republic of, 4Seoul National University Hospital, Seoul, Korea, Republic of, 5Surgery, Seoul National University College of Medicine, Seoul, Korea, Republic of

    *Purpose: Continuous glucose monitoring (CGM) provides a 24-hour view of glucose values and information on glycemic variability and additional indices such as the glucose management…
  • 2022 American Transplant Congress

    Epidemiology of Post Transplant Diabetes Mellitus

    S. Al Rasbi, I. Salmi

    Renal Medicine Department, The Royal Hospital, Bausher, Oman

    *Purpose: Diabetes mellitus (DM) is a common non-communicable disease and have serious metabolic complications that contribute to death, major cardiovascular events, organs failure, and increased…
  • 2022 American Transplant Congress

    Sodium-Glucose Co-Transporter 2 Inhibitors; Short-Term Outcome in Diabetic Kidney Transplant Recipients

    J. Yagan1, T. S. Mahmoud1, A. Hasan2, O. Gheith1, n. El-Serwy1, S. Rida1, M. Mostafa1, M. Shaker1, P. Nair1, T. Alotaibi1

    1Nephrology, Hamed Al-Essa Organ Transplant Center, Kuwait, Kuwait, 2Immunometabolism, Dasman Diabetes Center, Kuwait, Kuwait

    *Purpose: The idea of using SGLT2i in kidney transplant recipients (KTR) is a legitimate one after the recent encouraging data for their use in other…
  • 2022 American Transplant Congress

    Outcomes of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Diabetic Kidney Transplant Recipients

    T. S. Mahmoud1, J. Yagan1, A. Hasan2, O. Gheith1, M. Mostafa1, S. Rida1, N. El-Serwy1, M. Shaker1, M. Khalid1, P. Nair1, T. Alotaibi1

    1Nephrology, Organ Transplant Center, Kuwait, Kuwait, 2Immunometabolism, Dasman Diabetes Center, Kuwait, Kuwait

    *Purpose: The impact of the new glucose lowering therapies, sodium-glucose cotransporter 2 inhibitors (SGLT2i) and Glucagon-like peptide-1 receptor agonists (GLP-1RA), on managing patients with type…
  • 1
  • 2
  • 3
  • …
  • 11
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences